Coordinated Open Data Will Drive Next-Level Health Research
An Interview With European Data Cohesion Experts ELIXIR
Executive Summary
Experts from a European data sharing initiative talk to In Vivo about the importance of coordinated computational biology efforts for the future of life sciences innovation and the effective use of artificial intelligence.
You may also be interested in...
A Tale Of Two Pipelines
Immuno-oncology has produced some exciting successes, but the field has become intensely crowded. Enormous resources are being poured into duplicative work and shaky hypotheses—overshadowing other pursuits in cancer research while producing limited results. It is time to re-evaluate how the sector should be pursuing innovation in cancer and how it can be smarter in its use of resources—financial investment, talent, bandwidth, patients and data.
C-Suite Snippets: Open Data And Innovation
In case you missed it: catch up with snippets from interviews published by In Vivo this month.
Finding Value Left On The Shelf: Karuna Case Study
PureTech’s gamble to take an older Eli Lilly drug off the shelf to redevelop in a new indication paid off. The company aims to replicate this 'Karuna model' in the near future.